Though Lilly has been in the spotlight for the success of its GLP-1 drugs, the pharma giant has also been investing in a corporate brand campaign to boost its overall reputation.

The company is suing some online vendors and medical spas for selling copycats of a weight loss and diabetes drug.

Weaver Capital Management LLC lessened its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.0% in the 3rd quarter ...

GAM Holding AG raised its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 55.3% in the third quarter, ...

Aer Lingus will begin offering nonstop flights between Indianapolis and Dublin four times a week starting in May, marking the ...

We recently looked at Goldman Sachs’ List Of Stocks That Hedge & Mutual Funds Love & Hate: 28 Stocks On The Mutual and Hedge ...

Eli Lilly has filed three new separate lawsuits accusing vendors and a medical spa of selling knock-off versions of their ...

The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval ...

Ireland is currently the number one importer to the US state of Indiana, with shipments valued at €19.3bn for 2023 ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

Eli Lilly (LLY) announced that the Medicines and Healthcare products Regulatory Agency, or MHRA, has granted marketing authorization for ...